Summary
- Current Price
- As of today, ABT price is $107.96, up +2.13% on
- Current Price All-Time High
- ABT price is currently -24.29% below its historical high of $142.60 set on
- Market Cap
- ABT current market cap is $188B, down -18.19% year-over-year
- PE Ratio
- ABT current PE ratio is 34.90
- Revenue
- ABT current annual revenue is $44.33B, up +5.67% year-over-year
- Next Earnings
- The next earnings release for ABT is on
Profile
| Metric | Value |
|---|---|
| Full Name | Abbott Laboratories |
| Ticker | NYSE: ABT |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | |
| Website | abbott.com |
| Employees | 114,000 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $107.96 | |
| Price, 1D Change | +2.13% | |
| Market Cap | $188B | |
| TTM Dividend Yield | 2.30% | |
| PE Ratio | 34.90 | |
| Beta | 0.04 | |
| Revenue | $44.33B | |
| Revenue, 1Y Change | +5.67% | |
| EPS | $3.72 | |
| EPS, 1Y Change | -51.32% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.63 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 5000:2399 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $3.72 | |
| EPS Estimate | $5.52 | N/A |
| EPS Est. Change | +48.37% | N/A |
| Revenue | $44.33B | |
| Revenue Estimate | $50.30B | N/A |
| Revenue Est. Change | +13.48% | N/A |
| Current Price | $107.96 | |
| Price Target | $118.50 | - |
| Price Tgt. Change | +9.76% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $4.67 | $7.64 | +63.38% | |
| $5.17 | $3.72 | -28.11% | |
| $5.52 | N/A | +48.37% | |
| $6.06 | N/A | +63.04% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $41.99B | $41.95B | -0.09% | |
| $44.67B | $44.33B | -0.78% | |
| $50.30B | N/A | +13.48% | |
| $54.65B | N/A | +23.28% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | -18.25% | |
| Price, 3Y | -0.45% | |
| Market Cap, 1Y | -18.19% | |
| Market Cap, 3Y | -0.08% | |
| Revenue, 1Y | +5.67% | |
| Revenue, 3Y | +1.55% | |
| EPS, 1Y | -51.32% | |
| EPS, 3Y | -5.00% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $107.96 | |
| SMA 200 | $107.89 | |
| SMA 50 | $94.82 | |
| EMA 200 | $105.26 | |
| EMA 50 | $97.94 | |
| MACD | $3.71 | |
| Beta | 0.04 | |
| ATR | $2.99 | |
| 14-Day RSI | 67.91 | |
| 10-Day Volatility | 25.60% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $0.63 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 2.19% | |
| Total Dividend | $2.36 | |
| Dividends Paid | $4.12B | |
| Payout Ratio | 63.32% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $44.33B | |
| EPS | $3.72 | |
| Gross Profit | $25.14B | |
| Gross Margin | 56.71% | |
| Operating Income | $8.39B | |
| Operating Margin | 18.93% | |
| Net Income | $6.50B | |
| Net Margin | 14.72% | |
| EBITDA | $11.38B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.27 | |
| Current Ratio | 1.58 | |
| Quick Ratio | 1.18 | |
| - | ||
| Piotroski F-Score | 4 | |
| Altman Z-Score | 5.09 |
Valuations
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $52.13B | |
| Cash & Equivalents | $8.94B | |
| Total Assets | $86.71B | |
| Current Assets | $26.00B | |
| Total Liabilities | $33.94B | |
| Current Liabilities | $16.50B | |
| Total Debt | $14.14B | |
| Short Term Debt | $3.31B | |
| Accounts Payable | $4.24B |
Expenses
| Metric | Value | Date |
|---|---|---|
| Total Expenses | $37.80B | |
| Operating Expenses | $16.75B | |
| Cost Of Goods Sold | $19.19B | |
| SG&A | $0.00 | |
| D&A | $3.12B | |
| Interest Expense | $0.00 | |
| Income Tax | $1.94B |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| CFO | $9.57B | |
| CFI | -$2.42B | |
| CFF | -$6.31B | |
| Capex | $2.17B | |
| Free Cash Flow | $7.40B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| UBS | → | |
| Wells Fargo | → | |
| TD Cowen | → | |
| RBC Capital | → | |
| Piper Sandler | → | |
| JP Morgan | → | |
| Evercore ISI Group | → | |
| Citigroup | → | |
| BTIG | → | |
| Evercore ISI Group | → |
Analyst sentiment
Institutional ownership
Screeners with ABT
FAQ
- What is the ticker symbol for Abbott Laboratories?
- The ticker symbol for Abbott Laboratories is NYSE:ABT
- Does Abbott Laboratories pay dividends?
- Yes, Abbott Laboratories pays dividends. The last payment was $0.63, with an ex-dividend date on July 15, 2026
- What sector is Abbott Laboratories in?
- Abbott Laboratories is in the Healthcare sector
- What industry is Abbott Laboratories in?
- Abbott Laboratories is in the Medical Devices industry
- What country is Abbott Laboratories based in?
- Abbott Laboratories is headquartered in United States
- When did Abbott Laboratories go public?
- Abbott Laboratories initial public offering (IPO) was on March 17, 1980
- Is Abbott Laboratories in the S&P 500?
- Yes, Abbott Laboratories is included in the S&P 500 index
- Is Abbott Laboratories in the NASDAQ 100?
- No, Abbott Laboratories is not included in the NASDAQ 100 index
- Is Abbott Laboratories in the Dow Jones?
- No, Abbott Laboratories is not included in the Dow Jones index
- When was Abbott Laboratories last earnings report?
- Abbott Laboratories's most recent earnings report was on July 16, 2026
- When does Abbott Laboratories report earnings?
- The next expected earnings date for Abbott Laboratories is October 14, 2026
Data Sources & References
- ABT Official Website www.abbott.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- ABT Profile on Yahoo Finance finance.yahoo.com/quote/ABT
- ABT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abt
